MAXROTEC Co., Ltd. (KOSDAQ:A141070) agreed to acquire 17.06% stake in Sungwun Pharmacopia Co. Ltd. for KRW 4.2 billion on October 7, 2020. As reported, MAXROTEC Co., Ltd. will acquire 0.61 million shares in Sungwun Pharmacopia Co. Ltd. The acquisition funds will be paid as the 5th convertible bond issued by MAXROTEC Co., Ltd. Sungwun Pharmacopia reported total assets of KRW 9.4 billion, total equity of KRW 2.8 billion and net loss of KRW 3.1 billion at the end of 2019. The transaction was resolved by the Board of Directors of MAXROTEC Co. on October 7, 2020. The acquisition is expected to be completed on October 7, 2020.